According to Future Market Insights, the global nasal allergy treatment market is poised for substantial growth, with its valuation expected to double from USD 6.6 billion in 2022 to USD 13.3 billion ...

Tablets/Capsules segment is set to lead in terms of the form of seasonal allergy with a projected market value share of ...

If the freezing weather wasn’t enough, this past week has been nothing short of miserable — my household has gone through ...

The Food and Drug Administration’s (FDA or Agency) final rule on Additional Conditions for Nonprescription Use (ACNU) paves the way for some ...

Preliminary fourth quarter neffy® net product revenue of approximately $6.5 millionPreliminary cash, cash equivalents and short-term investments ...